AI Proteins
Latest round
- Series A
Last raised
- Nov 2025
Total raised
- $34M
Investors
- 4
About AI Proteins
Founded in 2021 by Carl Novina, Chris Bahl (CSO), Marc Cohen, and based in Massachusetts, US, AI Proteins, Inc. operates as a biotechnology-based company that uses artificial intelligence to design synthetic proteins to help produce various therapeutic medicines. In November 2025, AI Proteins, Inc. The company develops novel therapeutics and medicines by designing and engineering synthetic miniproteins from scratch using robotics and the firm's computational protein design.
Who invested in AI Proteins
4 investors across 2 rounds
See all investors in AI Proteins
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AI Proteins
Who invested in AI Proteins?
AI Proteins has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AI Proteins raised?
AI Proteins has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AI Proteins last raise money?
AI Proteins's most recent round on record is a Series A, in Nov 2025.
What does AI Proteins do?
Founded in 2021 by Carl Novina, Chris Bahl (CSO), Marc Cohen, and based in Massachusetts, US, AI Proteins, Inc.
Where is AI Proteins headquartered?
AI Proteins is headquartered in Boston, US.
Which VCs invest in companies like AI Proteins?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AI Proteins's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AI Proteins? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.